Skip to main content
. 2017 Mar 8;57(7):876–885. doi: 10.1002/jcph.876

Figure 1.

Figure 1

Goodness‐of‐fit diagnostics for the simulated pharmacokinetic model. (A) Observed secukinumab concentration versus population‐predicted secukinumab concentration. (B) Observed secukinumab concentration versus individual‐predicted secukinumab concentration. (C) Conditional weighted residual versus population‐predicted secukinumab concentration. (D) Conditional weighted residual versus time.